LO
CapabilityCognitive automation2020-02-07
The US FDA authorised AI guidance for cardiac ultrasound after a study in which registered nurses with no scanning experience acquired limited ten-view heart scans
Sonographeroccupation page →
Event date / reported
2020-02-07
Evidence stage
CapabilityA demo, benchmark or paper shows the task can be done. Updates what the technology can do — not what employers will do.
Tasks this bears on
Getting the standard views
Positioning the probe and the patient to capture the standard images an examination requires, and judging when each one is good enough.
Being augmented≈ Platform inference
Checking and teaching scans done by others
Reviewing image quality from point-of-care scans done by nurses, doctors and other staff, and training them.
New task≈ Platform inference
Where this applies
The FDA's own decision summary for the De Novo request DEN190040 (Caption Guidance). The summary's only date line, 27 August 2019, is when the request was received; the FDA's De Novo database record gives the decision — granted on 7 February 2020 — and that is the date used here. The software is indicated to assist medical professionals in acquiring standard views of adult transthoracic echocardiography; the pivotal study validated its use by users with no prior scanning experience to acquire limited ten-view, point-of-care echocardiograms, and the summary describes its automatic capture as emulating the way a sonographer knows an image is of sufficient quality. Its warnings leave image quality with the user and require interpretation by qualified medical professionals. It establishes what the product may be marketed to do, not how widely it is used or whether it replaces full examinations.
What this means
A regulator has accepted that software can guide people who have never scanned through a limited heart ultrasound, by telling them how to move the probe and capturing the image when it is good enough. For a sonographer that makes routine views faster to get — and opens a limited scan to nurses and other staff, whose images someone who knows ultrasound will need to check.
What it does not yet show
An authorisation says what the product may be sold to do; it does not show how widely it is used, whether it is used instead of full examinations, or any change in how many sonographers hospitals employ.
What you can check
Open the FDA decision summary DEN190040 and read the indications for use, the paragraph on the pivotal nurse study ('users with no prior scanning experience'), the description of automatic capture, and the warnings; check the decision date in the FDA's De Novo database record for DEN190040.
Does it change the assessment?
No — and this stage does not move it either. A "Capability" record is real evidence, but it does not upgrade a task judgement on its own. The 2 linked judgements above stand where they were.
Source
U.S. FDA — De Novo decision summary DEN190040, Caption Guidance (decision date from the FDA De Novo database record) · verified 2026-09-26 · Claude (VOLO agent) · interpreted 2026-09-26 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.